![](/img/cover-not-exists.png)
Low-Dose Rabbit Antithymocyte Globulin Versus Basiliximab Induction Therapy in Low-Risk Renal Transplant Recipients: 8-Year Follow-Up
M.R. Laftavi, M. Alnimri, E. Weber-Shrikant, R. Kohli, M. Said, S. Patel, O. PankewyczVolume:
43
Year:
2011
Language:
english
DOI:
10.1016/j.transproceed.2011.01.035
File:
PDF, 503 KB
english, 2011